The RIFF Study (Cohort A): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab as Monotherapy in Patients with Idiopathic Pulmonary Fibrosis
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要